295 related articles for article (PubMed ID: 25267681)
41. Potential antiviral agents of Rosmarinus officinalis extract against herpes viruses 1 and 2.
Al-Megrin WA; AlSadhan NA; Metwally DM; Al-Talhi RA; El-Khadragy MF; Abdel-Hafez LJM
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469389
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of antiviral activities of four local Malaysian Phyllanthus species against herpes simplex viruses and possible antiviral target.
Tan WC; Jaganath IB; Manikam R; Sekaran SD
Int J Med Sci; 2013; 10(13):1817-29. PubMed ID: 24324358
[TBL] [Abstract][Full Text] [Related]
43. Antiviral Properties of the LSD1 Inhibitor SP-2509.
Harancher MR; Packard JE; Cowan SP; DeLuca NA; Dembowski JA
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699090
[TBL] [Abstract][Full Text] [Related]
44. Antiviral and virucidal activities against herpes simplex viruses of umesu phenolics extracted from Japanese apricot.
Nishide M; Ikeda K; Mimura H; Yoshida M; Mitani T; Hajime Koyama A
Microbiol Immunol; 2019 Sep; 63(9):359-366. PubMed ID: 31301156
[TBL] [Abstract][Full Text] [Related]
45. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
46. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
[TBL] [Abstract][Full Text] [Related]
47. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
48. Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments.
Lukonis CJ; Burkham J; Weller SK
J Virol; 1997 Jun; 71(6):4771-81. PubMed ID: 9151871
[TBL] [Abstract][Full Text] [Related]
49. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
Priengprom T; Ekalaksananan T; Kongyingyoes B; Suebsasana S; Aromdee C; Pientong C
BMC Complement Altern Med; 2015 Mar; 15():56. PubMed ID: 25879785
[TBL] [Abstract][Full Text] [Related]
50. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
51. Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity.
Kalke K; Lehtinen J; Gnjatovic J; Lund LM; Nyman MC; Paavilainen H; Orpana J; Lasanen T; Frejborg F; Levanova AA; Vuorinen T; Poranen MM; Hukkanen V
Viruses; 2020 Dec; 12(12):. PubMed ID: 33322225
[TBL] [Abstract][Full Text] [Related]
52. Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus.
Field HJ; Biswas S
Drug Resist Updat; 2011 Feb; 14(1):45-51. PubMed ID: 21183396
[TBL] [Abstract][Full Text] [Related]
53. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
54. Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens.
Arbuckle JH; Gardina PJ; Gordon DN; Hickman HD; Yewdell JW; Pierson TC; Myers TG; Kristie TM
mBio; 2017 Aug; 8(4):. PubMed ID: 28811345
[TBL] [Abstract][Full Text] [Related]
55. Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to aciclovir.
Harris W; Collins P; Fenton RJ; Snowden W; Sowa M; Darby G
J Gen Virol; 2003 Jun; 84(Pt 6):1393-1401. PubMed ID: 12771406
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
[TBL] [Abstract][Full Text] [Related]
57. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
58. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
59. The potency of acyclovir can be markedly different in different cell types.
Brand G; Schiavano GF; Balestra E; Tavazzi B; Perno CF; Magnani M
Life Sci; 2001 Aug; 69(11):1285-90. PubMed ID: 11521752
[TBL] [Abstract][Full Text] [Related]
60. The Peptide A-3302-B Isolated from a Marine Bacterium
Sureram S; Arduino I; Ueoka R; Rittà M; Francese R; Srivibool R; Darshana D; Piel J; Ruchirawat S; Muratori L; Lembo D; Kittakoop P; Donalisio M
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
